Novartis, Bristol-Myers end Zelnorm deal

Novartis (NVS; SWX:NOVN) and BMY agreed to terminate their Zelnorm/ Zelmac tegaserod development and marketing collaboration following a non-approvable letter issued in June by the FDA. Separately, NV...